Patents Assigned to Envision Biomedical LLC
  • Publication number: 20250092174
    Abstract: Hydrogel materials used in the manufacture of biocompatible medical devices, for example, hydrogel materials having desirable physical properties for use as a contact lens. A composition contains at least one vinyl containing monomer, a methacrylate(acrylate) monomer, methacrylate (acrylate) prepolymers, crosslinking agents and monomers having the structure as shown in Formula 1: where R1 is a vinyl functionality capable of radical polymerization with specific preference for N-vinyl lactam derivatives and R2 is a zwitterionic functionality. The materials utilize a two-phase polymerization strategy.
    Type: Application
    Filed: November 21, 2024
    Publication date: March 20, 2025
    Applicant: Envision Biomedical LLC
    Inventors: Jay Friedrich Künzler, Siddhesh Pawar
  • Patent number: 11905351
    Abstract: A composition includes at least one siloxy-based (meth)acrylate monomer or prepolymer, at least one additional methacrylate monomer, UV, and Visible light blocking agents and one or more crosslinking agents. The final product results in a highly wettable material that possesses physical properties such as a low modulus of elasticity and high oxygen permeability without the need for a non-reactive solubilizing agent and that are free of cyclic and linear siloxanes.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: February 20, 2024
    Assignee: Envision Biomedical LLC
    Inventor: Jay Friedrich Künzler
  • Publication number: 20240026049
    Abstract: Hydrogel materials used in the manufacture of biocompatible medical devices, for example, hydrogel materials having desirable physical properties for use as a contact lens. A composition contains at least one vinyl containing monomer, a methacrylate(acrylate) monomer, methacrylate (acrylate) prepolymers, crosslinking agents and monomers having the structure as shown in Formula 1: where R1 is a vinyl functionality capable of radical polymerization with specific preference for N-vinyl lactam derivatives and R2 is a zwitterionic functionality. The materials utilize a two-phase polymerization strategy.
    Type: Application
    Filed: July 19, 2023
    Publication date: January 25, 2024
    Applicant: Envision Biomedical LLC
    Inventors: Jay Friedrich KÜNZLER, Siddhesh PAWAR
  • Publication number: 20210317244
    Abstract: A composition includes at least one siloxy-based (meth)acrylate monomer or prepolymer, at least one additional methacrylate monomer, UV, and Visible light blocking agents and one or more crosslinking agents. The final product results in a highly wettable material that possesses physical properties such as a low modulus of elasticity and high oxygen permeability without the need for a non-reactive solubilizing agent and that are free of cyclic and linear siloxanes.
    Type: Application
    Filed: April 9, 2021
    Publication date: October 14, 2021
    Applicant: Envision Biomedical LLC
    Inventor: Jay Friedrich KÜNZLER